Uncategorized

Prepackaged Meds in Standard Sizes

One of the biggest challenges of repackaging medications for clinics is managing the wide variations in prescribing patterns.  Physicians that offer pharmaceutical dispensing generally focus on a few items that they frequently prescribe and that are prescribed in standard pill counts.  This enables the clinic to minimize inventory while maximizing products dispensed to patients.

PCA Pharmaceuticals and other repackagers try to do the same thing.  We want to offer the largest variety of prepackaged medications possible while balancing the various sizes with what is most frequently prescribed at the clinic level.  With medication expiration dates ranging from 18-24 months from when we repackage them, it becomes a priority to get pharmaceuticals off the shelf as quickly as possible.

Here are a few suggestions for clinics that offer pharmaceutical dispensing to consider when discussing prepackaged medications with their distributor:

  1. If the repackager does not have the exact pill count you want, what is the closest option?  We often get requests for an item in 18, 20 or 21 pill counts.  We will try to match the clinic with the closest standard bottle size we carry.
  2. Is there an alternative for the item you requested?  Frequently, there are other alternatives that are therapeutically similar to the product you requested.
  3. If you must have a particular medication in a specific size not offered by your repackager, consider how many you plan to use over a period of time.  Your distributor may be willing to custom pack them for you if it looks likely you will use the inventory over a reasonable time period.

Fortunately, most medication dispensing focuses on a relatively narrow range of pharmaceuticals.  Your distributor will do everything possible to meet your requirements. We appreciate your patience as we work through the nuances of your practice!

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading